Mitoxantrone‐Based Novel Conditioning Regimen Leads to Great Survival Benefit in Peripheral T‐Cell Lymphoma Compared to <scp>BEAM</scp> Regimen
ASCT with the mitoxantrone-based conditioning regimen is tolerable and appears to significantly improve the prognosis of PTCL patients, offering a promising alternative to the current standard of care.
Authors
- Wensi Qian (ORCID: https://orcid.org/0000-0003-2591-0003)
- Jiexian Ma (ORCID: https://orcid.org/0000-0002-5102-5158)
- Xinyu Zuo (ORCID: https://orcid.org/0000-0002-4953-288X)
- Yanhui Xie
- Min Wu
Institutions
- Fudan University (CN)
- Huadong Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70476
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- Science and Technology Commission of Shanghai Municipality